Dr. Reddy's Laboratories (RDY) said Thursday it is recalling one batch of levetiracetam in 0.75% sodium chloride injection, 1,000 mg/100 mL single-dose infusion bags across the US.
The company said it is recalling the product due to the incorrect labeling of the infusion bag which reads as levetiracetam in 0.82% sodium chloride injection 500 mg/100 mL single-dose bag, while the aluminum overwrap packaging is correctly labeled as levetiracetam in 0.75% sodium chloride injection 1,000 mg/100 mL.
The pharmaceutical company distributed the batch between Nov. 4 and Nov. 6 to wholesalers, it said, adding that the recall is being taken place under the knowledge of the US Food and Drug Administration.
Dr. Reddy's shares were up 1.3% in recent Thursday trading.
Price: 12.70, Change: +0.17, Percent Change: +1.32
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。